Extended-spectrum β-lactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the era of lowered breakpoints and no confirmatory tests.
| Image |  |
|---|---|
| Description | scientific article published on 11 June 2012 |
| Author/s |
author: Keith Kaye Ashish Bhargava Kayoko Hayakawa |
| Publication date | June 11, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |